Spago Nanomedical AB (OSTO:SPAGO) 3-Year EBITDA Growth Rate : 14.00% (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Spago Nanomedical AB 3-Year EBITDA Growth Rate?

Spago Nanomedical AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-0.02.

During the past 3 years, the average EBITDA Per Share Growth Rate was 14.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Spago Nanomedical AB was 43.50% per year. The lowest was -26.30% per year. And the median was 12.60% per year.

Competitive Comparison of Spago Nanomedical AB's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Spago Nanomedical AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spago Nanomedical AB's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spago Nanomedical AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Spago Nanomedical AB's 3-Year EBITDA Growth Rate falls into.

Spago Nanomedical AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Spago Nanomedical AB (OSTO:SPAGO) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Spago Nanomedical AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Spago Nanomedical AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Spago Nanomedical AB (OSTO:SPAGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (OSTO:SPAGO) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

7UX:Germany

Address

Scheelevagen 22, Lund, SWE, SE-223 63

Website

https://www.spagonanomedical.se

Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.

Spago Nanomedical AB (OSTO:SPAGO) Headlines

No Headlines